| Chemotherapy drug  | 
Minimum breakthrough detection time, ASTM D6978 | 
| Blenoxane (Bleomycin), 15 mg/mL (15,000 ppm) | 
>240 minutes | 
| Cisplatin 1 mg/mL (1000 ppm) | 
>240 minutes | 
| Cyclophosphamide, 20 mg/mL (20,000 ppm) | 
>240 minutes | 
| Cytarabine, 100 mg/mL (100,000 ppm) | 
>240 minutes | 
| Dacarbazine 10 mg/mL (10,000 ppm) | 
>240 minutes | 
| Doxorubicin HCl 2 mg/mL (2000 ppm) | 
>240 minutes | 
| Etoposide (Toposar), 20 mg/mL (20,000 ppm) | 
>240 minutes | 
| Fluorouracil (5 Flu), 50 mg/mL (50,000 ppm) | 
>240 minutes | 
| Idarubicin, 1 mg/mL (1000 ppm) | 
>240 minutes | 
| Mesna, 100 mg/mL (100,000 ppm) | 
>240 minutes | 
| Methotrexate 25 mg/mL (25,000 ppm) | 
>240 minutes | 
| Mitomycin C, 0.5 mg/mL (500 ppm) | 
>240 minutes | 
| Paclitaxel, 6 mg/mL (6000 ppm) | 
>240 minutes | 
| Trisenox, 1 mg/mL (1000 ppm) | 
>240 minutes | 
| Vincristine Sulfate, 1 mg/mL (1000 ppm) | 
>240 minutes |